Yotam Nisemblat, MSc, MBA

linkedin-icon-32x32.png

CEO

MSc from Tel-Aviv University in Neurobiology with specialization in Alzheimer's disease and MBA from The Interdisciplinary Center in Herzliya. BSc from the Technion, Israel Institute of Technology (Haifa, Israel) in Biotechnology and Food Engineering. Over twelve years of industry experiences in drug development research and management, mainly in the field of CNS-related disorders. Former Drug Development Director at BioLineRx